Johnson & Johnson vs Unilever plc — how do they compare? Johnson & Johnson trades at $259.01 (market cap $626.09B), while Unilever plc trades at $61.89 (market cap $134.06B). The key difference: Johnson & Johnson is far larger — about 4.7× Unilever plc's market cap, and Unilever plc pays the higher dividend (3.65%). Which is the better fit depends on your goals.
| JNJ | UL | |
|---|---|---|
Market Cap | $626.09B | $134.06B |
Volume | 6,156,228 | — |
Sector | Health | Consumer Staples |
52-Week High | $267.24 | $74.59 |
52-Week Low | $172.78 | $55.05 |
Enterprise Value | $654.37B | $159.86B |
Dividend Yield | 2.06% | 3.65% |
Trailing returns across standard periods
Latest headlines on both assets
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →Unilever is a diversified personal product (42% of 2021 sales by value), home care (20%), and packaged food (38%) company. Its brands include Knorr soups and sauces, Hellmann's mayonnaise, Lipton teas, Axe and Dove skin products, and the TRESemme haircare brand. The firm has been acquisitive in recent years
Read more on UL →